All GLG News Analyses Filed Under: Industrial

An interesting analysis, which only validates a trend that cuts across other capital intensive manufacturing industries as well!

Airbus' plans for a narrowbody assembly-line in Tianjin, China, are running more than a year behind schedule and costing EADS far more than anticipated.

There are several major players in the field of heat exchangers: Alfa Laval, Global Engineering Alliance (GEA), Hisaka, SWEP. Most comprehensive range of heat exchangers is offered by Alfa Laval, GEA, and APV. Hisaka offers more industrial type of heat exchangers, while SWEP specializes in the brazed...

World Wildlife Federation-sponsored "Climate Savers" is a bell-weather group for voluntary carbon market and environmental action. Climate Savers' leaders are expanding their sights beyond their own emissions reductions to encourage reductions in their supply chains and their customers. Future demand...

An independent report into DOD procurement aspects of the war in Iraq is strongly critical of alleged delays in U.S. sourcing and deployment of Mine Resistant Ambush Protected (MRAP) vehicles, credited in the past six months with a sharp drop in the U.S. casualty rate.

There is an important change happening in Brazil: decision makers will have to consider long term projects if the assumtption is availability of energy for their facilities. This is a huge difference in a country with a tradition for short term projects only. A whole new world is there to be d...

The current record aerospace industry order cycle will not be sustained by strong growth from Russia and Eastern Europe, no matter what the Russians themselves might say. Potential, yes, practicality, not yet...

· Commercial construction is going strong in Western Canada, supporting the paint/coating industry, and is expected to continue through 2009. · Building permits for commercial buildings were up 10% through July 2007.

· Overseas sales helped to offset a weak North American chemicals market. · Higher petroleum, gas, and other raw materials costs adversely effected profit margins in 2007.

Biopharmaceuticals (large-molecular therapeutic drugs) are beginning to pay-off for contract manufacturers. Contract fine chemical companies that produce/service the biologics area are seeing increasing demand.